• AAPL 168
  • TSLA 155.45
  • AMZN 181.28
  • MSFT 411.84
  • INTC 35.68
  • EURUSD 1.0675
Overview Fundamentals API Earnings EOD API Sample Code Pricing
Register now
Free trial

No credit cards required

Get free API key
  1. Supported exchanges /
  2. PINK /
  3. IPSEF.PINK

Ipsen S.A (IPSEF PINK) stock market data APIs

$117.6 0(0%) as of April 17, 2024

Ipsen S.A Financial Data Overview

117.6
117.6
-
117.6
117.6
108.75-123.75
9 726 M
14.9239
82 705 K
3 306 M
2.1499
0.0109
0.636
Our easy-to-use no-coding solutions help you get the data effortlessly:
Excel Financial Add-In Google Sheets Financial Add-In Python
APIs SDK Windows Downloader

No long-term obligations. The minimum period is one month only. No wait. You get an API key with instructions in a few seconds right after subscription.

General: {
Code: 'IPSEF',
Type: 'Common Stock',
Name: 'Ipsen S.A',
Exchange: 'PINK',
CurrencyCode: 'USD',
CurrencyName: 'US Dollar',
CurrencySymbol: '$',
CountryName: 'USA',
CountryISO: 'US',
OpenFigi: 'BBG000GNNSP7',
ISIN: NULL,
CUSIP: NULL,
CIK: NULL,
EmployerIdNumber: NULL,
FiscalYearEnd: 'December',
IPODate: NULL,
InternationalDomestic: NULL,
Sector: 'Healthcare',
Industry: 'Drug Manufacturers - Specialty & Generic',
HomeCategory: NULL,
IsDelisted: false,
}

Ipsen S.A Fundamental Data is available in our Financial Data APIs

  • Net Revenue 3 306 M
  • EBITDA 1 143 M
  • Earnings Per Share 7.88
  • Income Statements
  • Balance Sheets
  • Cash flows
Fundamental data package from $59.99 See full price
Get sample
of Fundamental API Data

Get Ipsen S.A Earnings via APIs

  • Latest Release 2021-06-30
  • EPS/Forecast 0

Get Ipsen S.A End-of-day Data via APIs

  • End of Day, Intraday and Live APIs
  • Splits
  • Dividends

Get Ipsen S.A latest news via APIs

Ipsen publishes its 2023 Universal Registration Document

Ipsen Pharma Ipsen publishes its 2023 Universal Registration Document PARIS, FRANCE, 17 April 2024 - Ipsen (Euronext: IPN; ADR: IPSEY), a global specialty biopharmaceutical group, announces that i...

Marengo Therapeutics Announces First Drug Candidate Nomination from Oncology Collaboration with Ipsen

A Novel TCR Vβ bifunctional selective T cell activator molecule for solid tumor treatment Marengo to receive an associated milestone payment and eligible for additional future milestone payments, an...
Do you have any questions?
support@eodhistoricaldata.com